(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BIXITO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BIXITO

ST13

US500000079318920

Class

5

Filing

79318920

Registration

6635264

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

04/21/2023

Trademark type

Word

Nice classes

5

Filing date

07/28/2021

Registration date

02/08/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/08/2022

Last transaction

04/21/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

DOMBROW, COLLEEN M

Law office

L10

Current location

PETITIONS OFFICE

Holders and representatives

Holders

Novartis AG

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Publications

History of USPTO decisions and trademark events.

29 publications found

GPNX

NOTIFICATION PROCESSED BY IB

06/21/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/26/2022

FIMP

FINAL DISPOSITION PROCESSED

05/26/2022

CORN

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED

05/26/2022

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

03/10/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

02/08/2022

RNWL

INTERNATIONAL REGISTRATION RENEWED

01/03/2022

GPNX

NOTIFICATION PROCESSED BY IB

12/12/2021

CHPB

POST PUBLICATION AMENDMENT - ENTERED

12/08/2021

APET

ASSIGNED TO PETITION STAFF

12/01/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/23/2021

PUBO

PUBLISHED FOR OPPOSITION

11/23/2021

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

11/18/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/17/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/17/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/03/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/21/2021

DOCK

ASSIGNED TO EXAMINER

10/16/2021

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

09/19/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/15/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/15/2021

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

09/15/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/15/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/15/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/15/2021

MAFR

APPLICATION FILING RECEIPT MAILED

09/07/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/01/2021

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

08/30/2021

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

08/26/2021

Continuous trademark protection

Get notified about every new filing that threatens BIXITO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.